-
公开(公告)号:WO2005021551A1
公开(公告)日:2005-03-10
申请号:PCT/US2004/029246
申请日:2004-08-23
申请人: AMGEN INC. , NUNES, Joseph J. , ZHU, Xiaotian , ERMANN, Monika , GHIRON, Chiara , JOHNSTON, David N. , SALUSTE, Carl-Gustaf Pierre
发明人: NUNES, Joseph J. , ZHU, Xiaotian , ERMANN, Monika , GHIRON, Chiara , JOHNSTON, David N. , SALUSTE, Carl-Gustaf Pierre
IPC分类号: C07D487/14
CPC分类号: C07D487/14
摘要: The present invention relates to tetracyclic pyrimidines or pyridines or pharmaceutically-acceptable salts or derivatives thereof. Also included are methods of use of the tetracyclic pyrimidines or pyridines including use related to treating inflammation, inhibiting T cell activation and proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease and many other related disorders in a subject, the methods comprising administering a therapeutically-effective amount a compound as described above to the subject.
摘要翻译: 本发明涉及四环嘧啶或吡啶或其药学上可接受的盐或衍生物。 还包括使用四环嘧啶或吡啶的方法,包括与治疗炎症有关的用途,抑制T细胞活化和增殖,关节炎,器官移植,缺血或再灌注损伤,心肌梗死,中风,多发性硬化,炎性肠病等许多方法 所述方法包括向受试者施用治疗有效量的如上所述的化合物。
-
公开(公告)号:WO2004048378A1
公开(公告)日:2004-06-10
申请号:PCT/SE2003/001805
申请日:2003-11-21
申请人: ACTIVE BIOTECH AB , MATTHEWS, Ian, Richard , COULTER, Thomas, Stephen , GHIRON, Chiara , BRENNAN, Chris, James , UDDIN, Muhammed, Kamal , PETTERSSON, Lars, Olof, Göran , THRIGE, Dorthe da Graça , HUXLEY, Philip
发明人: MATTHEWS, Ian, Richard , COULTER, Thomas, Stephen , GHIRON, Chiara , BRENNAN, Chris, James , UDDIN, Muhammed, Kamal , PETTERSSON, Lars, Olof, Göran , THRIGE, Dorthe da Graça , HUXLEY, Philip
IPC分类号: C07D471/06
CPC分类号: C07D519/00 , C07D471/04 , C07D491/04 , C07D495/04
摘要: The present invention relates to novel heterocyclic compounds, to methods for their preparation, to compositions containing them, and to methods and use for clinical treatment of medical conditions which may benefit from immunomodulation, including rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis. More particularly the present invention relates to novel heterocyclic compounds, which are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.
摘要翻译: 本发明涉及新的杂环化合物,其制备方法,含有它们的组合物,以及用于临床治疗可能受益于免疫调节的医学病症的方法和用途,所述免疫调节包括类风湿性关节炎,多发性硬化,糖尿病,哮喘,移植, 系统性红斑狼疮和牛皮癣。 更具体地说,本发明涉及能够抑制CD80和CD28之间相互作用的CD80拮抗剂的新型杂环化合物。
-
公开(公告)号:WO2009051718A3
公开(公告)日:2009-06-11
申请号:PCT/US2008011755
申请日:2008-10-15
申请人: AMGEN INC , COULTER THOMAS S , FOTSCH CHRISTOPHER H , GHIRON CHIARA , HARRINGTON PAUL E , KELLY MICHAEL G , MILLER PHILIP , RISHTON GILBERT M , ST JEAN DAVID J JR , SEMIN DAVID J
发明人: COULTER THOMAS S , FOTSCH CHRISTOPHER H , GHIRON CHIARA , HARRINGTON PAUL E , KELLY MICHAEL G , MILLER PHILIP , RISHTON GILBERT M , ST JEAN DAVID J JR , SEMIN DAVID J
IPC分类号: C07D207/48 , A61K31/40 , A61K31/415 , A61K31/4164 , A61P7/00 , C07D207/335 , C07D231/12 , C07D231/16 , C07D231/22 , C07D233/64 , C07D261/08 , C07D271/06 , C07D277/28 , C07D401/04
CPC分类号: C07D233/64 , C07D207/335 , C07D207/48 , C07D231/12 , C07D231/16 , C07D231/22 , C07D261/08 , C07D271/06 , C07D277/28 , C07D401/04
摘要: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I.
摘要翻译: 本发明一般涉及新型拟钙剂化合物和包含它们的药物组合物。 本发明还涉及使用式I代表的化合物治疗与钙敏感受体功能有关的疾病或病症的方法。
-
4.MODULATORS OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF 审中-公开
标题翻译: ALPHA7烟碱乙酰胆碱受体调节剂及其治疗应用公开(公告)号:WO2007082731A1
公开(公告)日:2007-07-26
申请号:PCT/EP2007/000381
申请日:2007-01-17
申请人: SIENA BIOTECH S.P.A. , BOTHMANN, Hendrick , RONCARATI, Renza , MICCO, Iolanda , NENCINI, Arianna , GHIRON, Chiara
IPC分类号: C07D295/20 , A61P25/28 , A61P29/00
CPC分类号: C07D211/26 , C07D211/58 , C07D295/215
摘要: Compounds with α7 nicotinic acetylcholine receptor (α7 nAChR) agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological and psychiatric diseases.
摘要翻译: 具有α7烟碱乙酰胆碱受体(α7nAChR)激动活性的化合物,其制备方法,含有该化合物的药物组合物及其用于治疗神经和精神疾病的用途。 p>
-
公开(公告)号:WO2009051718A2
公开(公告)日:2009-04-23
申请号:PCT/US2008/011755
申请日:2008-10-15
申请人: AMGEN INC. , COULTER, Thomas S. , FOTSCH, Christopher H. , GHIRON, Chiara , HARRINGTON, Paul E. , KELLY, Michael G. , MILLER, Philip , RISHTON, Gilbert M. , ST. JEAN, David J., Jr. , SEMIN, David J.
发明人: COULTER, Thomas S. , FOTSCH, Christopher H. , GHIRON, Chiara , HARRINGTON, Paul E. , KELLY, Michael G. , MILLER, Philip , RISHTON, Gilbert M. , ST. JEAN, David J., Jr. , SEMIN, David J.
IPC分类号: C07D207/48 , C07D231/12 , C07D231/16 , C07D231/22 , C07D233/64 , C07D261/08 , C07D271/06 , C07D277/28 , C07D401/04 , C07D207/335 , A61K31/415 , A61K31/4164 , A61K31/40 , A61P7/00
CPC分类号: C07D233/64 , C07D207/335 , C07D207/48 , C07D231/12 , C07D231/16 , C07D231/22 , C07D261/08 , C07D271/06 , C07D277/28 , C07D401/04
摘要: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I.
摘要翻译: 本发明一般涉及新型的拟钙化合物和包含它们的药物组合物。 本发明还涉及使用式I表示的化合物治疗与钙感受受体的功能相关的疾病或病症的方法。
-
6.MODULATORS OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF 审中-公开
标题翻译: ALPHA7非线性乙酰胆碱受体的调节剂及其治疗用途公开(公告)号:WO2007098826A2
公开(公告)日:2007-09-07
申请号:PCT/EP2007000382
申请日:2007-01-17
申请人: SIENA BIOTECH SPA , WYETH PHARMACEUTICALS , BOTHMANN HENDRICK , RONCARATI RENZA , BETTINETTI LAURA , QUINN JOANNA , VARRONE MAURIZIO , VALACCHI MICHELA , NENCINI ARIANNA , MICCO IOLANDA , GHIRON CHIARA , HAYDAR SIMON
发明人: BOTHMANN HENDRICK , RONCARATI RENZA , BETTINETTI LAURA , QUINN JOANNA , VARRONE MAURIZIO , VALACCHI MICHELA , NENCINI ARIANNA , MICCO IOLANDA , GHIRON CHIARA , HAYDAR SIMON
IPC分类号: C07D211/60 , C07C231/00 , C07D213/38 , C07D213/40 , C07D231/12 , C07D231/40 , C07D233/54 , C07D233/88 , C07D295/12 , C07D295/14 , C07D295/18 , C07D401/04 , C07D403/12 , C07D409/04
CPC分类号: C07D295/15 , C07C237/08 , C07C237/42 , C07D211/60 , C07D213/38 , C07D213/40 , C07D231/12 , C07D231/40 , C07D233/54 , C07D233/88 , C07D295/13 , C07D295/185 , C07D401/04 , C07D403/12 , C07D409/04
摘要: Compounds with a7 nicotinic acetylcholine receptor (a7 nAChR) agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological and psychiatric diseases.
摘要翻译: 具有α7烟碱乙酰胆碱受体(a7 nAChR)激动活性的化合物,其制备方法,含有它们的药物组合物及其用于治疗神经和精神疾病的用途。
-
7.MODULATORS OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF 审中-公开
标题翻译: ALPHA7烟碱乙酰胆碱受体调节剂及其治疗应用公开(公告)号:WO2006008133A3
公开(公告)日:2006-03-23
申请号:PCT/EP2005007846
申请日:2005-07-19
申请人: SIENA BIOTECH SPA , GAVIRAGHI GIOVANNI , GHIRON CHIARA , BOTHMANN HENDRICK , RONCARATI RENZA , TERSTAPPENN GEORG CHRISTIAN
发明人: GAVIRAGHI GIOVANNI , GHIRON CHIARA , BOTHMANN HENDRICK , RONCARATI RENZA , TERSTAPPENN GEORG CHRISTIAN
IPC分类号: C07D295/12 , A61K31/445 , A61P25/28 , C07D209/08 , C07D211/60 , C07D213/40 , C07D215/46 , C07D243/08 , C07D295/14 , C07D333/20 , C07D401/12 , C07D409/12
CPC分类号: C07D213/40 , C07D209/08 , C07D209/18 , C07D211/52 , C07D211/60 , C07D213/56 , C07D213/82 , C07D215/38 , C07D217/04 , C07D239/26 , C07D243/08 , C07D295/13 , C07D295/15 , C07D295/185 , C07D319/18 , C07D333/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D409/12
摘要: The present invention relates to compounds with a7 nAChR agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological, psychiatric, cognitive, immunological and inflammatory disorders.
摘要翻译: 本发明涉及具有α7nAChR激动活性的化合物,其制备方法,含有该化合物的药物组合物及其用于治疗神经,精神,认知,免疫和炎症疾病的用途。
-
公开(公告)号:WO2008087529A1
公开(公告)日:2008-07-24
申请号:PCT/IB2008/000090
申请日:2008-01-16
申请人: SIENA BIOTECH S.P.A. , WYETH PHARMACEUTICALS , GHIRON, Chiara , NENCINI, Arianna , MICCO, Iolanda , ZANALETTI, Riccardo , MACCARI, Laura , BOTHMANN, Hendrick , HAYDAR, Simon , VARRONE, Maurizio , PRATELLI, Carmela , HARRISON, Boyd
发明人: GHIRON, Chiara , NENCINI, Arianna , MICCO, Iolanda , ZANALETTI, Riccardo , MACCARI, Laura , BOTHMANN, Hendrick , HAYDAR, Simon , VARRONE, Maurizio , PRATELLI, Carmela , HARRISON, Boyd
IPC分类号: C07D231/40 , C07D401/04 , C07D403/04 , C07D403/12 , C07D403/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D413/12 , C07D473/04 , C07D487/04 , A61K31/4155 , A61P25/00
CPC分类号: C07D401/04 , C07D231/40 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D471/04
摘要: The present invention provides compounds of formula (I) and compositions thereof, methods of making them, and methods of using them to modulate alpha7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory system.
摘要翻译: 本发明提供式(I)化合物及其组合物,其制备方法以及使用它们调节α7烟碱乙酰胆碱受体和/或治疗多种疾病,疾病和病症中的任何一种的方法。 提供的化合物可以影响神经系统,精神和/或炎症系统。
-
公开(公告)号:WO2007098826A3
公开(公告)日:2007-09-07
申请号:PCT/EP2007/000382
申请日:2007-01-17
申请人: SIENA BIOTECH S.P.A. , WYETH PHARMACEUTICALS , BOTHMANN, Hendrick , RONCARATI, Renza , BETTINETTI, Laura , QUINN, Joanna , VARRONE, Maurizio , VALACCHI, Michela , NENCINI, Arianna , MICCO, Iolanda , GHIRON, Chiara , HAYDAR, Simon
发明人: BOTHMANN, Hendrick , RONCARATI, Renza , BETTINETTI, Laura , QUINN, Joanna , VARRONE, Maurizio , VALACCHI, Michela , NENCINI, Arianna , MICCO, Iolanda , GHIRON, Chiara , HAYDAR, Simon
IPC分类号: C07D211/60 , C07D213/38 , C07D213/40 , C07D231/12 , C07D231/40 , C07D233/54 , C07D233/88 , C07D295/12 , C07D295/14 , C07D295/18 , C07D401/04 , C07D403/12 , C07D409/04 , C07C231/00
摘要: Compounds with α7 nicotinic acetylcholine receptor (α7 nAChR) agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological and psychiatric diseases.
-
10.2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES 审中-公开
标题翻译: 2-氨基-4-羟基-5-嘧啶甲酰胺衍生物及相关化合物作为T细胞活化的抑制剂治疗炎症性疾病公开(公告)号:WO2005009443A1
公开(公告)日:2005-02-03
申请号:PCT/US2004/020243
申请日:2004-06-24
申请人: AMGEN INC. , NUNES, Joseph J. , ZHU, Xiaotian , AMOUZEGH, Patricia , GHIRON, Chiara , JOHNSTON, David N. , POWER, Eoin, Christopher
发明人: NUNES, Joseph J. , ZHU, Xiaotian , AMOUZEGH, Patricia , GHIRON, Chiara , JOHNSTON, David N. , POWER, Eoin, Christopher
IPC分类号: A61K31/506
CPC分类号: C07D213/82 , C07D239/47 , C07D239/48
摘要: The present invention relates to pyrimidine or pyridine carboxamides or pharmaceutically-acceptable salts thereof. Also included is a method of treatment of inflammation, inhibition of T cell activation and proliferation, arthritis, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, organ transplant, acute transplant or heterograft or homograft rejection, transplantation tolerance induction, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, including ulcerative colitis, Crohn's disease, lupus, contact hypersensitivity, delayed-type hypersensitivity, and gluten-sensitive enteropathy, type 1 diabetes, psoriasis, contact dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune polyglandular disease, autoimmune alopecia, pernicious anemia, vitiligo, autoimmune hypopituatarism, Guillain-Barre syndrome, glomerulonephritis, serum sickness, uticaria, allergic diseases, asthma, hayfever, allergic rhinitis, scleracielma, mycosis fungoides, dermatomyositis, alopecia areata, chronic actinic dermatitis, eczema, Behcet's disease, Pustulosis palmoplanteris, Pyoderma gangrenum, Sezary's syndrome, atopic dermatitis, systemic schlerosis, morphea, atopic dermatitis, colon carcinoma or thymoma in a mammal comprising administering a therapeutically-effective amount a compound as described above.
摘要翻译: 本发明涉及嘧啶或吡啶甲酰胺或其药学上可接受的盐。 还包括治疗炎症,抑制T细胞活化和增殖,关节炎,类风湿性关节炎,银屑病关节炎,骨关节炎,器官移植,急性移植或异种移植或同种移植物排斥,移植耐受性诱导,缺血或再灌注损伤,心肌梗死的方法 ,中风,多发性硬化,炎症性肠病,包括溃疡性结肠炎,克罗恩病,狼疮,接触性超敏反应,迟发型超敏反应和麸质敏感性肠病,1型糖尿病,牛皮癣,接触性皮炎,桥本氏甲状腺炎,干燥综合征,自身免疫性甲状腺功能亢进 ,艾迪生病,自身免疫性多腺病,自身免疫性脱发,恶性贫血,白癜风,自身免疫性低位症,吉兰巴利综合征,肾小球性肾炎,血清病,荨麻疹,过敏性疾病,哮喘,高粱,过敏性鼻炎,巩膜瘤,蕈样真菌病,皮肌炎,秃头症 ,慢性交感 包括给予治疗有效量的如上所述的化合物,包括给予治疗有效量的上述化合物,其中,所述治疗有效量的治疗有效量的药物组合物包含给药治疗有效量的化合物。
-
-
-
-
-
-
-
-
-